臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"hsu c h"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 791-815 / 1656 (共67頁)
<< < 27 28 29 30 31 32 33 34 35 36 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2020-05-25T07:35:34Z	A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer	Chia-Chi Lin; Cheng A.-L; Hsu C.-H; Lu Y.-S; Hsu C; Yeh K.-H; Wu C.-Y; Huang C.-S; Yang C.-H.
臺大學術典藏	2020-05-25T07:35:34Z	Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancer	Lee J.-M; Yeh K.-H; Yang C.-H; Lin J.-T; Cheng A.-L; Lee Y.-C.; Lee Y.-C.;Cheng A.-L;Lin J.-T;Yang C.-H;Yeh K.-H;Lee J.-M;Wang H.-P;Cheng J.C;Hsu C.-H;Chia-Chi Lin; Chia-Chi Lin; Hsu C.-H; Cheng J.C; Wang H.-P
臺大學術典藏	2020-05-25T07:35:34Z	Complete response of urothelial carcinoma to chemotherapy in renal allograft recipients: A two-case study	Pu Y.-S.;Hsu C.-H;Chia-Chi Lin; Chia-Chi Lin; Hsu C.-H; Pu Y.-S.
臺大學術典藏	2020-05-25T07:35:34Z	Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity	Pu Y.-S.;Vogelzang N.J;Chen J;Cheng A.-L;Huang C.-Y;Hsu C.-H;Chia-Chi Lin; Chia-Chi Lin; Hsu C.-H; Huang C.-Y; Cheng A.-L; Chen J; Vogelzang N.J; Pu Y.-S.
臺大學術典藏	2020-05-25T07:35:33Z	Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study	Chia-Chi Lin; Hsu C.-H; Huang C.-Y; Keng H.-Y; Tsai Y.-C; Huang K.-H; Cheng A.-L; Pu Y.-S.
臺大學術典藏	2020-05-25T07:35:33Z	Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens	Chia-Chi Lin; Hsu C.-H; Huang C.-Y; Tsai Y.-C; Huang K.-H; Cheng A.-L; Pu Y.-S.
臺大學術典藏	2020-05-25T07:35:33Z	Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma	Chia-Chi Lin; Hsu C.-H; Huang C.-Y; Cheng A.-L; Vogelzang N.J; Pu Y.-S.
臺大學術典藏	2020-05-25T07:35:32Z	Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment	Yang C.-H.;Yang P.-C;Cheng A.-L;Chia-Chi Lin;Hsu C.-H;Yu C.-J;Chang Y.-C;Hsu C;Lin Z.-Z; Lin Z.-Z; Hsu C; Chang Y.-C; Yu C.-J; Hsu C.-H; Chia-Chi Lin; Cheng A.-L; Yang P.-C; Yang C.-H.
臺大學術典藏	2020-05-25T07:35:32Z	Systemic therapy for metastatic urothelial carcinoma	Chia-Chi Lin; Hsu C.-H; Pu Y.-S; Vogelzang N.J.
臺大學術典藏	2020-05-25T07:35:32Z	Weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in hormone-refractory prostate cancer: In vitro combined effects and a Phase II trial	Chia-Chi Lin; Hsu C.-H; Hour T.-C; Cheng A.-L; Huang C.-Y; Huang K.-H; Chen J; Pu Y.-S.
臺大學術典藏	2020-05-25T07:35:32Z	Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma	Hsu C.-H.;Cheng A.-L;Hsu W.-L;Tsai Y.-C;Hsu C;Yang C.-H;Yeh K.-H;Chia-Chi Lin; Chia-Chi Lin; Yeh K.-H; Yang C.-H; Hsu C; Tsai Y.-C; Hsu W.-L; Cheng A.-L; Hsu C.-H.
臺大學術典藏	2020-05-25T07:35:31Z	Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: Results of a retrospective non-randomized study	Cheng J.C.-H.;Lee Y.-C;Tsai Y.-C;Hsu C.-H;Chang Y.-L;Lee J.-M;Chia-Chi Lin;Hsu F.-M; Hsu F.-M; Chia-Chi Lin; Lee J.-M; Chang Y.-L; Hsu C.-H; Tsai Y.-C; Lee Y.-C; Cheng J.C.-H.
臺大學術典藏	2020-05-25T07:35:30Z	Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma	Chia-Chi Lin; Pu Y.-S; Hsu C.-H; Keng H.-Y; Cheng A.-L; Yang C.-H.
臺大學術典藏	2020-05-25T07:35:29Z	Association of clinical and dosimetric factors with postoperative pulmonary complications in esophageal cancer patients receiving intensity-modulated radiation therapy and concurrent chemotherapy followed by thoracic esophagectomy	Hsu F.-M; Lee Y.-C; Lee J.-M; Hsu C.-H; Chia-Chi Lin; Tsai Y.-C; Wu J.-K; Cheng J.C.-H.
臺大學術典藏	2020-05-25T07:35:29Z	Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer	Huang C.-Y; Cheng J.C; Chia-Chi Lin; Hsu C.-H; Tsai Y.-C; Hsu F.-M; Huang K.-H; Cheng A.-L; Pu Y.-S.
臺大學術典藏	2020-05-25T07:35:27Z	Polymorphism in epidermal growth factor receptor intron 1 predicts prognosis of patients with esophageal cancer after chemoradiation and surgery	Lee J.-M; Yang S.-Y; Yang P.-W; Shun C.-T; Wu M.-T; Hsu C.-H; Chia-Chi Lin; Cheng J.-C.-H; Wang Y.-H; Chuang T.-H; Chen J.-S; Hsu H.-H; Huang P.-M; Kuo S.-W; Lee Y.-C.
臺大學術典藏	2020-05-25T07:35:27Z	Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma	Tsai Y.-C; Hsu C.-H; Chia-Chi Lin; Hsu F.-M; Lee J.-M; Huang P.-M; Lee Y.-C; Chia-Hsien Cheng J.
臺大學術典藏	2020-05-25T07:35:24Z	Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapy	Chen W.-W; Chia-Chi Lin; Huang T.-C; Cheng A.-L; Yeh K.-H; Hsu C.-H.
臺大學術典藏	2020-05-25T07:35:22Z	A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies	Chia-Chi Lin; Su W.-C; Yen C.-J; Hsu C.-H; Su W.-P; Yeh K.-H; Lu Y.-S; Cheng A.-L; Huang D.C.-L; Fritsch H; Voss F; Taube T; Yang J.C.-H.
臺大學術典藏	2020-05-25T07:35:20Z	Systematic review and network meta-analysis: Neoadjuvant chemoradiotherapy for locoregional esophageal cancer	Huang T.-C; Hsu C.-H; Chia-Chi Lin; Tu Y.-K.
臺大學術典藏	2020-05-25T07:35:20Z	Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma	Guo J.-C; Huang T.-C; Chia-Chi Lin; Hsieh M.-S; Chang C.-H; Huang P.-M; Lee J.-M; Hsu F.-M; Cheng J.C.-H; Wang H.-P; Yeh K.-H; Cheng A.-L; Hsu C.-H.
臺大學術典藏	2020-05-25T07:35:15Z	A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement	Chiang Y; Cheng J.C.-H; Huang C.-Y; Tsai Y.-C; Chia-Chi Lin; Hsu C.-H; Cheng A.-L; Pu Y.-S.
臺大學術典藏	2020-05-25T07:35:12Z	Response to Nivolumab as Salvage Therapy in a Patient with Thymic Carcinoma	Yang P.-C; Guo J.-C; Hsieh M.-S; Chia-Chi Lin; Hsu C.-H.
臺大學術典藏	2020-05-25T07:35:12Z	Do We Need to Add Postoperative Radiotherapy in Patients Undergoing Trimodality Therapy for Esophageal Squamous Cell Carcinoma with Positive Lymph Nodes Disease?	Huang P.-M; Hsu F.-M; Chia-Chi Lin; Hsu C.-H; Cheng J.C.-H; Lee J.-M.
臺大學術典藏	2020-05-25T07:35:12Z	Number of resected lymph nodes and survival of patients with locally advanced esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy	Guo J.-C; Chia-Chi Lin; Huang T.-C; Huang P.-M; Kuo H.-Y; Chang C.-H; Wang C.-C; Cheng J.C.-H; Yeh K.-H; Hsu C.-H; Lee J.-M.

顯示項目 791-815 / 1656 (共67頁)
<< < 27 28 29 30 31 32 33 34 35 36 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 52718757 線上人數 : 614 教育部委託研究計畫計畫執行:國立臺灣大學圖書館